Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC
Phase 1
Completed
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- Drug: Durvalumab, Tremelimumab and ,FOLFOX
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 57
- Registration Number
- NCT03202758
- Locations
- 🇫🇷
CHU Nantes, Nantes, France
🇫🇷Hôpital Europeen Georges Pompidou, Paris, France
🇫🇷CHRU Besançon, Besançon, France
Preoperative Chemo-radiation With IG-IMRT Dose Escalation for Locally Advanced Rectal Cancers
Not Applicable
Completed
- Conditions
- Advanced Rectal Cancers
- Interventions
- Radiation: Preoperative chemo-radiation with IG-IMRT dose escalation
- First Posted Date
- 2017-06-27
- Last Posted Date
- 2020-06-24
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 15
- Registration Number
- NCT03200249
- Locations
- 🇫🇷
Centre Gf Leclerc, Dijon, France
🇫🇷CHRU de Besançon, Besançon, France
Characteristics of the Intestinal Microbiota in Patients With Cancer
Not Applicable
Completed
- Conditions
- Oncology
- Interventions
- Biological: Collection of stool and serum samples
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 69
- Registration Number
- NCT03196609
- Locations
- 🇫🇷
Centre Georges-François Leclerc, Dijon, France
🇫🇷Hopital Universitaire Paul Brousse, Villejuif, France
Observational Study to Assess Adherence Oral Anticancer Therapies
Completed
- Conditions
- Adherence, Patient
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 200
- Registration Number
- NCT03195972
- Locations
- 🇫🇷
CGFL, Dijon, France
Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas
Not Applicable
Active, not recruiting
- Conditions
- Glioblastoma, Adult
- Interventions
- Device: Radiotherapy
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 67
- Registration Number
- NCT03181477
- Locations
- 🇫🇷
CHU Amiens Picardie, Amiens, France
🇫🇷CHU Besançon, Besançon, France
🇫🇷Centre Georges François Leclerc, Dijon, France
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
Not Applicable
Completed
- Conditions
- Breast Neoplasms
- Interventions
- Other: PET with FDGOther: Tumor exome analysis
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 23
- Registration Number
- NCT02850302
- Locations
- 🇫🇷
CGFL, Dijon, France
Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Not Applicable
Terminated
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Other: FDG Positron Emission TomographyOther: FCH Positron Emission Tomography
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 61
- Registration Number
- NCT02847468
- Locations
- 🇫🇷
Emilie REDERSTORFF, Dijon, France
A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
Not Applicable
Completed
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Other: Injection of [18F]-ODS2004436 radiotracer
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 20
- Registration Number
- NCT02847377
- Locations
- 🇫🇷
CGFL, Dijon, France
Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: ERIBULIN + G-CSF (Granulocyte-Colony Stimulating Factor)
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2020-06-24
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 95
- Registration Number
- NCT02841722
- Locations
- 🇫🇷
CGFL, Dijon, France
What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors
Completed
- Conditions
- Carcinoma
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 795
- Registration Number
- NCT02840604
- Locations
- 🇫🇷
CGFL, Dijon, France
© Copyright 2025. All Rights Reserved by MedPath